|
Day One, Tuesday, 1 April 2008
|
08.30 | Registration and welcome coffee
|
08.50 | Opening remarks and welcome from the Chair |
| | Mr Warren Todd, Executive Director,
International Disease Management Alliance
|
| CDM- A GLOBAL PERSPECTIVE |
|
09.00 | International keynote address:
Addressing the worldwide crisis of chronic disease
• Trends in chronic disease growth and expenditure
• Forces driving an increase in chronic disease
• International developments and innovative measures |
| | Mr Warren Todd, Executive Director,
International Disease Management Alliance
|
09.30 | Keynote address:
Taking a unified tact in implementing CDM in Australia
• A stepwise and collaborative approach
• Embracing the population-based methodology
• Integrating “systemness” across the continuum of care |
| | Assoc Prof Malcolm Battersby, Director,
Flinders Human Behaviour and Human Research Unit
|
10.00 | DM experts panel session:
Overcoming the key factors which preclude effective CDM
• How and why CDM has failed in the past
• Today’s obstacles and enablers to profitable CDM
• Success stories from the global market |
| | Mr Al Lewis, Executive Director,
Disease Management Purchasing Consortium International Dr Emad Rizk, President,
McKesson Health Solutions Dr Kathryn Antioch, Consultant,
Tellimed Assoc Prof Malcolm Battersby, Director,
Flinders Human Behaviour and Human Research Unit
|
10.45 | Morning tea and Speed Networking
|
| THE GOVERNMENT’S CDM MANDATE |
|
11.30 | NSW Health Department address:
The Government’s role in integrating the sectors
• Reducing costs by encouraging collaborative involvement
• Addressing conflict between the State and Federal systems
• Government expectations for the Broader Health Policy
• Future initiatives to streamline CDM |
| | Prof Katherine McGrath, Deputy Director General,
NSW Health Dept
|
11.55 | Panel session:
Moving forward: what’s required of the key stakeholders?
• What the Government has done and still needs to do
• Interfacing with the private sector
• Facilitating clinicians’ efforts at the coalface |
| | Moderator:
Prof Steven Leeder, Director,
Australian Health Policy Institute Prof Katherine McGrath, Deputy Director General,
NSW Health Dept Ms Christine Gee, President,
Australian Private Hospitals Association Dr Suhan Baskar, Director Hospital at Home Project,
Sydney Adventist Hospital Dr Andrew Boyden, National Director - Clinical Issues,
National Heart Foundation Dr Stan Goldstein, Senior Medical Advisor,
MBF
|
| THE BUSINESS CASE FOR CDM |
|
12.40 | International keynote address:
Learning lessons from market leaders
• The micro and macro business case for CDM: why would anyone do it and why should everyone do it?
• Savings vs. earnings for investment outlays
• The evolution from Disease Management to Health Management |
| | Dr Emad Rizk, President,
McKesson Health Solutions
|
13.05 | Networking lunch
|
14.05 | International keynote address:
From ROIs to VOIs: new methods of assessing investments
• Overcoming problems associated with measuring accurately
• Efficacy vs. efficiency
• Factoring time frames into predictive modelling |
| | Mr Al Lewis, Executive Director,
Disease Management Purchasing Consortium International
|
14.35 | Case study:
Examining the value of CDM programs in Australia
• Clinical results and projected ROIs
• Co-ordinating efforts across the sectors
• Training patients to become independent |
| | Assoc Prof Margarite Vale, Director,
The COACH Program
|
15.00 | Panel discussion:
Adapting American systems for the Australian landscape
• Translating an established system to fit a local market
• Crucial differences to consider in Australia’s health system
• Learning to operate effectively in a different environment |
| | Moderator:
Assoc Prof Malcolm Battersby, Director,
Flinders Human Behaviour and Human Research Unit Dr Laurie Williams, Chairman and Medical Director,
Tellimed Dr Andrew Wilson, Co-President,
McKesson Solutions Ms Fiona Lynch, Program Manager Health Development Unit,
Medibank Private Assoc Prof Margarite Vale, Director,
The COACH Program
|
15.45 | Afternoon tea
|
| PARTNERSHIPS AND ALLIANCES |
|
16.15 | Opportunities for private providers: assessing and embracing
• The private service potential in the new legislative setting
• Shifting the service profile
• Integrating services to promote collaboration |
| | Dr Stan Goldstein, Senior Medical Advisor,
MBF
|
16.40 | Executive panel session:
Managing a multi-provider environment
• Avoiding a 2-tiered healthcare system
• Co-ordinating efforts across the public and private sectors
• Addressing conflicting drivers between the two systems |
| | Moderator:
Assoc Prof Gawaine Powell Davies, CEO and Director,
UNSW Research Centre for Primary Health Care and Equity Prof Napier Thomson, President,
Royal Australasian College of Physicians Ms Mary Foley, Chief Executive Officer,
St Vincents and Mater Health Ms Kate Carnell AO, CEO,
Australian General Practice Network Dr Stan Goldstein, Senior Medical Advisor,
MBF Dr Tony Joseph, Director of Emergency Services,
Royal North Shore Public Hospital
|
17.30 | End of Day One and networking cocktail party
|
|
Day Two, Wednesday, 2 April 2008
|
08.30 | Arrival and welcome coffee
|
08.50 | Opening remarks and welcome from the Chair |
| | Mr Warren Todd, Executive Director,
International Disease Management Alliance
|
09.00 | Consumer panel session:
The Voice of the Patients forum
Real life patients share their experiences about what has worked, what hasn’t and what needs to be changed in the approach to CDM. |
| | Moderator:
Prof Steven Leeder, Director,
Australian Health Policy Institute
|
| LEVERAGING TECHNOLOGY FOR BETTER CDM |
|
09.30 | The impact of technology on healthcare delivery
• Inefficiencies of traditional records-management
• Time frames involved in the e-Health revolution
• Communicating between the public and private sectors
• Protecting privacy while accessing patient data |
| | Dr Ian Reinecke, CEO,
National eHealth Transition Authority
|
09.55 | Case study:
Enabling e-Health transformation: The Chronic Disease Management Network
• Why aren’t existing ICT approaches working?
• Changing the current paradigm to surmount the obstacles
• Generating health and business opportunities |
| | Prof Michael Georgeff, CEO,
Precedence Health Care
|
10.20 | The future of remote patient monitoring
• Empowering patients to support self-care
• Measurement precision as a means of reducing medical errors
• Facilitating clinical pathways
• Overcoming the barriers to RPM reform |
| | Prof Steve Bolsin, Consultant,
Tellimed
|
10.50 | Morning tea
|
| ENGAGING THE EMPLOYERS |
|
11.20 | Examining the financial impact of CD in the workforce
• Cost of absenteeism and presenteeism to Australian business
• Growth of the Australian corporate health field
• Comparing international corporate health measures |
| | Mr Roger McComiskie, Lead Partner, Health Practice Leader,
PricewaterhouseCoopers
|
11.45 | Reducing the cost of CD by working with employers
• The potential scope for employer CDM programs
• Business case: outlays vs. returns
• Measuring improvements in productivity |
| | Dr John Lang, MD,
Good Health Solutions
|
12.10 | Case study:
A CDM corporate success story
• Strategy development: partnering with private insurance and providers
• Implementation costs and financial returns
• What worked, what didn’t and what more needs to be done? |
| | Ms Louise Stewart, MD,
Revive Group
|
12.35 | Networking Lunch
|
| PHARMACEUTICALS IN CDM |
|
13.35 | Maximising the value of medicine by targeting non-compliance
• Repercussions of non-compliance on health costs
• Barriers to medication adherence
• Solutions to minimise non-compliance |
| | Assoc Prof Ines Krass, Pharmacy Dept Head,
Faculty of Pharmacy
|
14.00 | Case study:
Examining the value of Quality Use of Medicines Programs
• Successful strategies to increase compliance
• Clinical results of patient assistance programs
• Including QUM in CDM |
| | Emeritus Professor Lloyd Sansom, Chair,
Pharmacy Benefits Advisory Committee
|
14.25 | Panel session:
Reducing healthcare costs by aligning compliance initiatives
• Using adherence monitoring technology to improve compliance
• Incorporating compliance drivers into CDM
• Involving pharmacists in monitoring compliance |
| | Dr Emad Rizk, President,
McKesson Health Solutions Assoc Prof Ines Krass, Pharmacy Dept Head,
Faculty of Pharmacy Emeritus Professor Lloyd Sansom, Chair,
Pharmacy Benefits Advisory Committee Mr Sam Everingham, Director,
Stethoscope
|
15.10 | Afternoon tea
|
| THE FUTURE |
|
15.40 | Roundtable discussions
Discussion 1: Incorporating ‘Wellness’ in the present to control chronic disease in the future
Dr Emad Rizk, President, McKesson (USA)
Discussion 2: The science of motivating patients to maximise results
Leanne Wells, Policy and Development Manager, Australian General Practice Network
Discussion 3: Coordinating co-morbidities
Assoc Prof Malcolm Battersby, Director, Flinders Human Behaviour and Human Research Unit
|
16.30 | Panel discussion:
The future of CDM
• Main challenges being faced in Australia today
• Global strategies for the international market
• Market opportunities for key stakeholders
• Financial projections for CDM in the future |
| | Mr Al Lewis, Executive Director,
Disease Management Purchasing Consortium International Dr Emad Rizk, President,
McKesson Health Solutions Dr Laurie Williams, Chairman and Medical Director,
Tellimed Assoc Prof Malcolm Battersby, Director,
Flinders Human Behaviour and Human Research Unit
|
17.00 | Closing remarks and close of conference
|
